An open‐label 16‐week study of liraglutide in adolescents with obesity post‐sleeve gastrectomy

Up to 50% of adolescents who undergo metabolic and bariatric surgery (MBS) have obesity 3 years post-MBS, placing them at continued risk for the consequences of obesity.